✦ LIBER ✦

Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis

✍ Scribed by Nuttapong Ngamphaiboon, Tracey L. O’Connor, Pooja P. Advani, Ellis G. Levine, Ellen B. Kossoff

Book ID: 118821431
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 177 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-011-0035-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-per-cycle pegfilgrastim in breast c

Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide

✍ L. MONTELLA; R. ADDEO; R. GUARRASI; G. CENNAMO; V. FAIOLA; E. CAPASSO; M. CARAGL 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Pegfilgrastim alone or with ciproflaxin

Pegfilgrastim alone or with ciproflaxin significantly reduces febrile neutropenia and hospitalization vs G-CSF alone in breast cancer patients receiving neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC)

✍ G. von Minckwitz; Blohmer; A. Loehr; G. Raab; H. Eidtmann; B. Gerber; J. Hilfric 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Estimation of the incidence of febrile n

Estimation of the incidence of febrile neutropenia in women receiving docetaxel plus cyclophosphamide as adjuvant therapy for early-stage breast cancer: a large community-based retrospective study

✍ Rodolfo Eduardo Bordoni; Sally Taylor Haislip; James Walter Gilmore Jr; Joyce Sh 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 236 KB

P0164 Toxicity profiles of adjuvant doce

P0164 Toxicity profiles of adjuvant docetaxel-cyclophosphamide in Asian compared with caucasian patients with breast cancer

✍ Chow, L.W.C.; Biganzoli, L.; Leo, A. Di; Kuroi, K.; Han, H.S.; Patel, J.; Huang, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

MDM2SNP309 andTP53R72P associated with s

MDM2SNP309 andTP53R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide

✍ Masatsugu Okishiro; Seung Jin Kim; Ryo Tsunashima; Takahiro Nakayama; Kenzo Shim 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 281 KB

Docetaxel alternating with epirubicin an

Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients

✍ W.W. ten Bokkel Huinink; V. Lustig; R. Dubbelman; A. Hiemstra; S. Rodenhuis 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 339 KB